Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

ClinicalTrials.gov ID: NCT00911937

Public ClinicalTrials.gov record NCT00911937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 10:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Trial To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to assess the efficacy of a flexible dose regimen of fesoterodine on micturition related nocturnal urgency episodes.

Study identification

NCT ID
NCT00911937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
963 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2009 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Dec 4, 2018

2009 – 2011

United States locations

U.S. sites
112
U.S. states
37
U.S. cities
102
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site Goodyear Arizona 85395 —
Pfizer Investigational Site Litchfield Park Arizona 85340 —
Pfizer Investigational Site Phoenix Arizona 85020 —
Pfizer Investigational Site Tucson Arizona 85741 —
Pfizer Investigational Site Little Rock Arkansas 72205 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site La Mesa California 91942 —
Pfizer Investigational Site Newport Beach California 92660 —
Pfizer Investigational Site Roseville California 95661 —
Pfizer Investigational Site Sacramento California 95825 —
Pfizer Investigational Site San Diego California 92103-6204 —
Pfizer Investigational Site San Diego California 92103 —
Pfizer Investigational Site San Diego California 92108 —
Pfizer Investigational Site Tarzana California 91356 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Farmington Connecticut 06032 —
Pfizer Investigational Site New Britain Connecticut 06052 —
Pfizer Investigational Site Norwalk Connecticut 06850 —
Pfizer Investigational Site Dover Delaware 19904 —
Pfizer Investigational Site Bonita Springs Florida 34134 —
Pfizer Investigational Site Brooksville Florida 34601 —
Pfizer Investigational Site DeFuniak Springs Florida 32435 —
Pfizer Investigational Site Destin Florida 32541 —
Pfizer Investigational Site Leesburg Florida 34748 —
Pfizer Investigational Site Naples Florida 34102 —
Pfizer Investigational Site Ocala Florida 34471 —
Pfizer Investigational Site Ocala Florida 34474 —
Pfizer Investigational Site Pembroke Pines Florida 33024 —
Pfizer Investigational Site South Miami Florida 33143 —
Pfizer Investigational Site St. Petersburg Florida 33709 —
Pfizer Investigational Site Tallahassee Florida 32308 —
Pfizer Investigational Site Tampa Florida 33606 —
Pfizer Investigational Site Atlanta Georgia 30329-5102 —
Pfizer Investigational Site Coeur d'Alene Idaho 83814 —
Pfizer Investigational Site Chicago Illinois 60634 —
Pfizer Investigational Site Chicago Illinois 60654 —
Pfizer Investigational Site Fort Wayne Indiana 46825 —
Pfizer Investigational Site Jeffersonville Indiana 47130 —
Pfizer Investigational Site Iowa City Iowa 52242 —
Pfizer Investigational Site West Des Moines Iowa 50266 —
Pfizer Investigational Site Newton Kansas 67114 —
Pfizer Investigational Site Overland Park Kansas 66202 —
Pfizer Investigational Site Overland Park Kansas 66210 —
Pfizer Investigational Site Overland Park Kansas 66211 —
Pfizer Investigational Site Pratt Kansas 67124 —
Pfizer Investigational Site Madisonville Kentucky 42431 —
Pfizer Investigational Site Mount Sterling Kentucky 40353 —
Pfizer Investigational Site Shreveport Louisiana 71106 —
Pfizer Investigational Site Annapolis Maryland 21401 —
Pfizer Investigational Site Fall River Massachusetts 02720 —
Pfizer Investigational Site Hyannis Massachusetts 02601 —
Pfizer Investigational Site Milford Massachusetts 01757 —
Pfizer Investigational Site New Bedford Massachusetts 02740 —
Pfizer Investigational Site Watertown Massachusetts 02472 —
Pfizer Investigational Site Troy Michigan 48098 —
Pfizer Investigational Site Chaska Minnesota 55318 —
Pfizer Investigational Site Olive Branch Mississippi 38654 —
Pfizer Investigational Site St Louis Missouri 63110 —
Pfizer Investigational Site Lincoln Nebraska 68510 —
Pfizer Investigational Site Omaha Nebraska 68114 —
Pfizer Investigational Site Hamilton New Jersey 08690 —
Pfizer Investigational Site Brooklyn New York 11215 —
Pfizer Investigational Site Garden City New York 11530 —
Pfizer Investigational Site Kingston New York 12401 —
Pfizer Investigational Site Manlius New York 13104 —
Pfizer Investigational Site New York New York 10016 —
Pfizer Investigational Site Poughkeepsie New York 12601 —
Pfizer Investigational Site Burlington North Carolina 27215 —
Pfizer Investigational Site Cary North Carolina 27518 —
Pfizer Investigational Site Charlotte North Carolina 28207 —
Pfizer Investigational Site Concord North Carolina 28025 —
Pfizer Investigational Site Huntersville North Carolina 28078 —
Pfizer Investigational Site Salisbury North Carolina 28144 —
Pfizer Investigational Site Fargo North Dakota 58103 —
Pfizer Investigational Site Akron Ohio 44311 —
Pfizer Investigational Site Cincinnati Ohio 45249 —
Pfizer Investigational Site Columbus Ohio 43214 —
Pfizer Investigational Site Columbus Ohio 43221 —
Pfizer Investigational Site Dayton Ohio 45439 —
Pfizer Investigational Site Westerville Ohio 43081 —
Pfizer Investigational Site Portland Oregon 97225 —
Pfizer Investigational Site Bala-Cynwyd Pennsylvania 19004 —
Pfizer Investigational Site Bridgeville Pennsylvania 15017 —
Pfizer Investigational Site Lansdale Pennsylvania 19446 —
Pfizer Investigational Site Philadelphia Pennsylvania 19114 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15236 —
Pfizer Investigational Site Sellersville Pennsylvania 18960 —
Pfizer Investigational Site East Greenwich Rhode Island 02818 —
Pfizer Investigational Site Pawtucket Rhode Island 02860 —
Pfizer Investigational Site Warwick Rhode Island 02886 —
Pfizer Investigational Site Anderson South Carolina 29621 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site Bristol Tennessee 37620 —
Pfizer Investigational Site Kingsport Tennessee 37660 —
Pfizer Investigational Site Knoxville Tennessee 37920 —
Pfizer Investigational Site Milan Tennessee 38358 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site New Tazewell Tennessee 37825 —
Pfizer Investigational Site Bryan Texas 77802 —
Pfizer Investigational Site Dallas Texas 75231 —
Pfizer Investigational Site Houston Texas 77024 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Houston Texas 77079 —
Pfizer Investigational Site Plano Texas 75024 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Mountlake Terrace Washington 98043 —
Pfizer Investigational Site Seattle Washington 98104 —
Pfizer Investigational Site Spokane Washington 99207 —
Pfizer Investigational Site Menomonee Falls Wisconsin 53051 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00911937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2018 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00911937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →